Search research articles
Contact Us
Filters
Showing results (41-50 of 346) with videos related to
Page
of 35
Sort By:
British Journal of Clinical Pharmacology
|
May 29, 2020
Chimeric antigen receptor T-cell therapy toxicities
Uri Greenbaum, Partow Kebriaei, Samer A Srour, et al.
Journal of Biopharmaceutical Statistics
|
October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size
Yuan Ji, Lei Feng, Ping Liu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 12, 2013
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Kaci Wilhelm, Roy Chemaly, Rima Saliba, et al.
Journal of Geriatric Oncology
|
May 20, 2014
Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates
Holly M Holmes, Jude K A Des Bordes, Partow Kebriaei, et al.
Clinical Case Reports
|
September 28, 2020
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy
Francesco Paolo Tambaro, Sajad Khazal, Cesar Nunez, et al.
Cancer
|
June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity
Elias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.
Transplantation and Cellular Therapy
|
August 17, 2025
The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
October 18, 2023
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age
Rima M Saliba, Christopher G Kanakry, Shahinaz Gadalla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study
Simrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
The Lancet. Haematology
|
January 15, 2016
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
Shahrukh Hashmi, Mohammad Ahmed, M Hassan Murad, et al.
Page
of 35
Search research articles
Search
Showing results (41-50 of 346) with videos related to
Sort By:
Page
of 35
British Journal of Clinical Pharmacology
|
May 29, 2020
Chimeric antigen receptor T-cell therapy toxicities
Uri Greenbaum, Partow Kebriaei, Samer A Srour, et al.
Journal of Biopharmaceutical Statistics
|
October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size
Yuan Ji, Lei Feng, Ping Liu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
September 12, 2013
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Kaci Wilhelm, Roy Chemaly, Rima Saliba, et al.
Journal of Geriatric Oncology
|
May 20, 2014
Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates
Holly M Holmes, Jude K A Des Bordes, Partow Kebriaei, et al.
Clinical Case Reports
|
September 28, 2020
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy
Francesco Paolo Tambaro, Sajad Khazal, Cesar Nunez, et al.
Cancer
|
June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity
Elias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.
Transplantation and Cellular Therapy
|
August 17, 2025
The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
October 18, 2023
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age
Rima M Saliba, Christopher G Kanakry, Shahinaz Gadalla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study
Simrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
The Lancet. Haematology
|
January 15, 2016
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
Shahrukh Hashmi, Mohammad Ahmed, M Hassan Murad, et al.
Page
of 35